Jay Rosenberg, MD
Neurology · la Jolla, CANPI 1609804848
Payments from drug & device makers
Across 399 payments — averaging $164.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$41K
- Sanofi$11K
- Amgen$8K
- Novartis$1K
- Biogen$1K
- AstraZeneca$537
- plus $4K from 28 others
What the payments were for
- Consulting fees$3,6756%
- Speaking & faculty fees$41,44563%
- Travel & lodging$8,44813%
- Food & beverage$11,45917%
- Education$5171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 132 | $40,630 |
| Sanofi | 29 | $10,593 |
| Amgen(2 entities) | 25 | $8,005 |
| Novartis | 51 | $1,110 |
| Biogen | 33 | $1,107 |
| AstraZeneca | 8 | $537 |
| Genentech, Inc. | 7 | $445 |
| Sunovion Pharmaceuticals Inc. | 31 | $431 |
| Neurocrine Biosciences, Inc. | 6 | $319 |
| AbbVie(2 entities) | 15 | $247 |
| Medtronic(3 entities) | 3 | $239 |
| Teva Pharmaceuticals USA, Inc. | 11 | $218 |
| Bristol Myers Squibb | 2 | $204 |
| Boston Scientific | 4 | $198 |
| Axogen | 1 | $193 |
| Johnson & Johnson | 3 | $170 |
| TG Therapeutics, Inc. | 1 | $125 |
| Banner Life Sciences, LLC | 2 | $116 |
| Adamas Pharmaceuticals, Inc. | 6 | $110 |
| Merz North America, Inc. | 3 | $63 |
| Genentech USA, Inc. | 2 | $61 |
| Livanova USA, Inc. | 1 | $56 |
| Acorda Therapeutics, Inc | 3 | $54 |
| Amneal Pharmaceuticals LLC | 3 | $54 |
| Greenwich Biosciences, Inc. | 3 | $51 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Acadia Pharmaceuticals Inc | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Portola Pharmaceuticals, LLC | 2 | $28 |
| Lundbeck LLC | 1 | $23 |
| Mallinckrodt Enterprises LLC | 2 | $23 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavenclad$33,989
- AUBAGIO$9,751
- UPLIZNA$7,160
- Rebif$3,661
- TYSABRI$335
- AIMOVIG$239
- MAYZENT$233
- TECFIDERA$208
- AVANCE NERVE GRAFT$193
- AxoGuard Nerve Connector$193
- AxoGuard Nerve Protector$193
- AXOGUARD HA+ NERVE PROTECTOR$193
- AxoGuard Nerve Cap$193
- MAZOR X SYSTEM$164
- Vumerity$127
- BRIUMVI$125
- INGREZZA$124
- Ponvory$123
- ONGENTYS$121
- AJOVY$117
How this compares
$65,543 in reported general payments places this provider in the 85th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 13 | $309 |
| Memantine Hcl | 17 | $288 |
| Donepezil Hcl | 17 | $124 |
Paid to pharmacies, not to this prescriber.
Other neurology in la Jolla
- John Ravitsla Jolla$8.4M
- Jody Corey-Bloomla Jolla$2.3M
- Douglas Galaskola Jolla$1.5M
- Timothy CloughesyLos Angeles$33.1M
- Jack FlorinFullerton$13M
- David KudrowSanta Monica$12.8M
- Perminder BhatiaFresno$8.3M
- Perry ShiehLos Angeles$8.2M
- Benjamin FrishbergCarlsbad$8.2M
- Bruce CreeSan Francisco$8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.